Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
Chemical Research in Toxicology
|
March 1, 1990
Biochemical, structural, and functional properties of oxidized low-density lipoprotein
H Esterbauer, M Dieber-Rotheneder, G Waeg, et al.
Biochemical Society Transactions
|
December 1, 1990
Endogenous antioxidants and lipoprotein oxidation
H Esterbauer, M Dieber-Rotheneder, G Waeg, et al.
EXS
|
January 1, 1992
Inhibition of LDL oxidation by antioxidants
H Esterbauer, G Waeg, H Puhl, et al.
Journal of Nutritional Science and Vitaminology
|
January 1, 1992
Vitamin E and atherosclerosis: an overview
H Esterbauer, H Puhl, G Waeg, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
July 1, 1995
Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies
E Malle, L Hazell, R Stocker, et al.
Cancer Biotherapy
|
January 1, 1995
Inhibition of melanoma B16-F10 growth by lipid peroxidation product 4-hydroxynonenal
N Zarkovic, M H Tillian, J Schaur, et al.
The Journal of Clinical Investigation
|
March 15, 1996
Presence of hypochlorite-modified proteins in human atherosclerotic lesions
L J Hazell, L Arnold, D Flowers, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
July 1, 1997
Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis
I Kruman, A J Bruce-Keller, D Bredesen, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
August 15, 2000
Involvement of lipid peroxidation, oncogene expression and induction of apoptosis in the antitumorous activity of ferric-sorbitol-citrate
M Poljak-Blazi, M Kralj, M P Hadzija, et al.
The American Journal of Pathology
|
February 1, 1997
Immunological evidence for hypochlorite-modified proteins in human kidney
E Malle, C Woenckhaus, G Waeg, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
Chemical Research in Toxicology
|
March 1, 1990
Biochemical, structural, and functional properties of oxidized low-density lipoprotein
H Esterbauer, M Dieber-Rotheneder, G Waeg, et al.
Biochemical Society Transactions
|
December 1, 1990
Endogenous antioxidants and lipoprotein oxidation
H Esterbauer, M Dieber-Rotheneder, G Waeg, et al.
EXS
|
January 1, 1992
Inhibition of LDL oxidation by antioxidants
H Esterbauer, G Waeg, H Puhl, et al.
Journal of Nutritional Science and Vitaminology
|
January 1, 1992
Vitamin E and atherosclerosis: an overview
H Esterbauer, H Puhl, G Waeg, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
July 1, 1995
Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies
E Malle, L Hazell, R Stocker, et al.
Cancer Biotherapy
|
January 1, 1995
Inhibition of melanoma B16-F10 growth by lipid peroxidation product 4-hydroxynonenal
N Zarkovic, M H Tillian, J Schaur, et al.
The Journal of Clinical Investigation
|
March 15, 1996
Presence of hypochlorite-modified proteins in human atherosclerotic lesions
L J Hazell, L Arnold, D Flowers, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
July 1, 1997
Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis
I Kruman, A J Bruce-Keller, D Bredesen, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
August 15, 2000
Involvement of lipid peroxidation, oncogene expression and induction of apoptosis in the antitumorous activity of ferric-sorbitol-citrate
M Poljak-Blazi, M Kralj, M P Hadzija, et al.
The American Journal of Pathology
|
February 1, 1997
Immunological evidence for hypochlorite-modified proteins in human kidney
E Malle, C Woenckhaus, G Waeg, et al.
Page
of 4